<DOC>
	<DOCNO>NCT00986427</DOCNO>
	<brief_summary>This purpose study assess safety effectiveness Restasis速 ophthalmic emulsion versus emulsion alone ( Refresh Dry Eye therapy ) treatment brittle nails enhancement normal nail growth texture . The investigator think daily application Restasis速 nail nail bed patient brittle nails enhance nail growth improve nail texture affect unaffected nail .</brief_summary>
	<brief_title>Restasis Treatment Brittle Nails</brief_title>
	<detailed_description>This single center , investigator-blinded ( investigator mask ) , head head comparison Restasis速 vehicle , Refresh速 Dry Eye Therapy 24 patient . Three target fingernail identify subject . Two target nail two nail severe sign brittle nail syndrome . The third target nail normal nail , absence normal nail , patient 's second-healthiest appear nail . The patient normal-appearing nail untreated growth treat nail compare growth untreated normal nail , fourth target nail . Study medication apply target nail ( subject may also apply nails wish , except one nail untreated order determine subject 's baseline rate fingernail growth ) 24 week . The target nail assess visit , every four week . There 12-week follow period treatment complete . This 36 week study conduct one center . Adult male female patient meet inclusion exclusion criterion screen eligibility . The principal investigator his/her designee obtain informed consent patient protocol specific procedure perform .</detailed_description>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>must IRB approve write informed consent prior participate study related procedure Must male female patient 18 75 year age must diagnosis brittle meet criterion diagnosis brittle nail screen visit base least two follow sign symptom brittle nails select nail plate severe sign ( one ) target nail trachyonychia ( surface roughness ) lamellar onychoschizia ( horizontal layering/peeling longitudinal crack split distal edge ( raggedness ) must two fingernail brittle nail sign symptom identify baseline must two normal nearnormal nail hand female patient childbearing potential ( surgically sterile least 2 year postmenopausal ) must negative pregnancy baseline/day 1 may lactate sexually active female subject surgically sterile 2 year post menopausal must agree use contraception/birth control measure study ( e.g. , oral contraceptive , diaphragms spermicide , condom spermicide , intrauterine device , Norplant System , DepoProvera , tubal ligation ) . Monthly urine pregnancy test administer woman childbearing potential must agree self administer topical study medication , must agree complete study procedure must judge good health medical history physical examination must able adhere study visit schedule protocol requirement , include avoid use nail polish , adhesive nail , manicure duration study history surgery affect fingernail chronic nail biter pregnant , nursing , plan pregnancy prior study enrollment disturbance shape affect fingernail ( e.g. , due malformation underlie bone ) would interfere investigator 's ability evaluate photograph nail change onycholysis ( lift nail plate nail bed ) affect fingernails sign fungal bacterial infection affect fingernails history psoriasis lichen planus involve nail , active contact dermatitis involve affect fingernail use topical cosmetic medicate product affect nail within 2 week baseline visit receive oral antifungal treatment within 3 month baseline visit know suspected history genetic condition affect nail ( e.g. , Darier 's disease , nailpatella syndrome , tuberous sclerosis ) use investigational drug within previous 1 month 5 halflives investigational agent , whichever long , 3 month biologic unknown halflife know suspected substance abuse ( drug alcohol ) problem within previous 3 year unlikely comply study protocol prescribe treatment unsuitable reason opinion investigator chronic liver , heart , kidney , ( untreated ) thyroid disease current sign symptom severe , progressive , uncontrolled renal , hepatic , hematologic , gastrointestinal , endocrine , pulmonary , cardiac , neurologic , cerebral disease currently know malignancy history malignancy nonmelanoma skin cancer sign bacterial , fungal viral skin lesion may interfere evaluation target nail know sensitivity active inactive ingredient Restasis ( R ) Refresh ( R ) Dry Eye Therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>